Celebrating our 10th anniversary – Unlock our special offer today

Trial ‘shows switching to Juul reduces toxins like stopping smoking’

A clinical trial funded by Juul purports to show that switching to the company’s e-cigarette products reduces the risk of toxins in a similar manner to stopping smoking altogether
Read full article
I'm already a subscriber
Author default picture

Daniel Mollenkamp

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization